Press release
Alzheimers Disease Therapeutics Market to grow at a CAGR of 10.2% During 224-2031| Key Players: Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. among Others
Alzheimers Disease Therapeutics Market
Global Alzheimer's Disease (AD) Therapeutics Market reached US$ 3,600 million in 2023 and is expected to reach US$ 7,829 million by 2031, growing at a CAGR of 10.2% during the forecast period 2024-2031.
Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/alzheimers-disease-therapeutics-market
Alzheimer's Disease (AD) therapeutics refer to the range of treatments and interventions aimed at managing the symptoms and progression of Alzheimer's Disease, a neurodegenerative disorder characterized by cognitive decline, memory loss, and changes in behavior.
Key Developments:
❁ In June 2024, Eisai and Biogen launched the humanized anti-soluble aggregated amyloid-beta monoclonal antibody "LEQEMBI" in China, approved in January 2024 for treating mild cognitive impairment due to Alzheimer's disease and mild AD dementia. China is the third country to launch LEQEMBI, following the United States and Japan.
List of the Key Players in the Alzheimers Disease Therapeutics Market:
Eli Lilly and Company, Biogen Inc., AstraZeneca PLC, Roche Holding AG, Novartis International AG, Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., Amgen Inc., H. Lundbeck A/S among others.
Research Process:
Both primary and secondary data sources have been used in the global Alzheimers Disease Therapeutics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Segment Covered in the Alzheimers Disease Therapeutics Market:
By Drug Class: (NMDA Receptor Antagonists, Manufactured Combination, Cholinesterase Inhibitors, Others)
By Route of Administration: (Oral, Parenteral)
By Distribution Channel: (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
Regional Covered:
The global Alzheimers Disease Therapeutics Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.
Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=alzheimers-disease-therapeutics-market
Regional Analysis:
The global Alzheimers Disease Therapeutics Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Alzheimers Disease Therapeutics Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.
**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**
Points Covered:
⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Alzheimers Disease Therapeutics market segments, study objectives, and years considered.
⏩ Market Landscape: The competition in the Global Alzheimers Disease Therapeutics Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.
⏩ Companies Profiles: The global Alzheimers Disease Therapeutics market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.
⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.
⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Alzheimers Disease Therapeutics Market.
⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.
⏩ Research Findings: This section of the report showcases the findings and analysis of the report.
⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/alzheimers-disease-therapeutics-market
Frequently Asked Questions
● What is the expected growth rate of the global market for the forecast period?
● What are the key driving factors that are responsible to shape the fate of the Alzheimers Disease Therapeutics market during the forecast period?
● What will be the overall size of the market during the analysis period?
● What are the prominent market trends which influence the development of the Alzheimers Disease Therapeutics market across various regions?
● Who are the key market players and the market strategies that have helped them to secure the leading position in the global market?
● What are the challenges and threats that are likely to act as a barrier to the growth of the Alzheimers Disease Therapeutics market?
● What are the major opportunities that the companies can get to attain success in the world?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Alzheimers Disease Therapeutics Market to grow at a CAGR of 10.2% During 224-2031| Key Players: Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. among Others here
News-ID: 3693656 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United States Cancer CDK Inhibitors Market 2025 | Growth Drivers, Key Players & …
Market Size and Growth
Global Cancer CDK Inhibitors Market reached US$ 9.3 billion in 2023 and is expected to reach US$ 13.8 billion by 2031, growing at a CAGR of 5.2% during the forecast period 2024-2031.
Key Development:
United States: Recent Industry Developments
✅ In June 2025, Gilead Sciences and Kymera Therapeutics entered into an exclusive option and license agreement to develop novel oral molecular glue CDK2 degraders. This collaboration aims to accelerate the…
United States Urinalysis Testing Products Market 2025 | Growth Drivers, Trends & …
Market Size and Growth
Urinalysis Testing Products market is estimated to reach at a high CAGR of 7.3 % during the forecast period (2023-2030).
Key Development:
United States: Recent Industry Developments
✅ In April 2025, H.U. Group Holdings, Inc. and its subsidiary Fujirebio Holdings, Inc. received a $4.5 million grant from the Global Health Innovative Technology (GHIT) Fund to develop an ultrasensitive point-of-care urine test for tuberculosis.
Japan: Recent Industry Developments
✅ In June 2025,…
Global Green Hydrogen Market Projected to Grow at 20.9% CAGR Through 2031, Drive …
The Global Green Hydrogen Market is expected to grow at a CAGR of 20.9% during the forecast period (2024-2031), according to DataM Intelligence.
United States: Recent Industry Developments
✅ In September 2025, The Department of Energy announced $8 billion in funding for regional green hydrogen hubs under the Infrastructure Investment and Jobs Act.
✅ In August 2025, Plug Power commissioned the largest green hydrogen production facility in North America…
United States Castration Resistant Prostate Cancer Treatment Market 2025 | Growt …
Market Size and Growth
The Global Castration Resistant Prostate Cancer Treatment Market is expected to grow at a CAGR of 9% during the forecasting period (2024-2031).
Key Development:
United States: Recent Industry Developments
✅ In August 2025, the FDA approved the initiation of a Phase 1 trial for KTX-2001, an NSD2 inhibitor, in combination with darolutamide for metastatic castration-resistant prostate cancer patients who have progressed after prior androgen receptor pathway inhibitor treatment.
✅ In August…
More Releases for Alzheimer
Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion.
Data Bridge…
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly…
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is…
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,…
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports.
Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as…
